MRNACommon stockNASDAQ
MRNA Common stock
This is the ticker-level security page. The issuer is Moderna.
Security details
Issuer financial context
These figures belong to the issuer company, not to this security itself.
Revenue TTM
$2.2B
Net income TTM
-$3.1B
Total assets
$12.1B
Total debt
Not available
Total equity
$9.3B
Profit margin
Not available
ROE
-33.4%
ROA
-25.7%
Latest issuer financial snapshot: 2024-12-31